Guofeng Ma

696 total citations
19 papers, 464 citations indexed

About

Guofeng Ma is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Guofeng Ma has authored 19 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Guofeng Ma's work include Cancer, Hypoxia, and Metabolism (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune cells in cancer (5 papers). Guofeng Ma is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune cells in cancer (5 papers). Guofeng Ma collaborates with scholars based in China, Finland and Sweden. Guofeng Ma's co-authors include Ye Liang, Yuanbin Chen, Zhijuan Liang, Dan Li, Haitao Niu, Liping Wang, Zhilei Zhang, Zhao Zhang, Xuecheng Yang and Yongbo Yu and has published in prestigious journals such as The Oncologist, Cell Cycle and BMC Cancer.

In The Last Decade

Guofeng Ma

18 papers receiving 457 citations

Peers

Guofeng Ma

ONCOL

IMMUN

SURGE

Jae K. Lee United States

Junjie Qian China

Xinguo Zhu China

Maria Teresa Bilotta Italy

Wenli Lin China

Ayano Kabashima Japan

Sang Taek Oh South Korea

Zi-Hao Qi China

Deli Mao China

Yu P China

Jae K. Lee United States

Guofeng Ma

165 ×0.8

98 ×0.5

119 ×0.9

ONCOL

107 ×0.8

IMMUN

87 ×1.1

SURGE

Citations per year, relative to Guofeng Ma Guofeng Ma (= 1×) peers Jae K. Lee

Countries citing papers authored by Guofeng Ma

Since Specialization

Citations

This map shows the geographic impact of Guofeng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofeng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofeng Ma more than expected).

Fields of papers citing papers by Guofeng Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guofeng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofeng Ma. The network helps show where Guofeng Ma may publish in the future.

Co-authorship network of co-authors of Guofeng Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Guofeng Ma. A scholar is included among the top collaborators of Guofeng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guofeng Ma. Guofeng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ma, Guofeng, Zhiqiang Li, Liping Wang, et al.. (2024). Gefitinib Reverses PD-L1–Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer. Cancer Immunology Research. 13(1). 66–83. 3 indexed citations

Li, Chengjun, et al.. (2024). SLC16A3 is a Prognostic Marker and Affects Immune Regulation in Bladder Cancer. Combinatorial Chemistry & High Throughput Screening. 28(12). 2091–2106.

Wang, Liping, Zhijuan Liang, Dan Li, et al.. (2023). Synthesis and application of zeolitic imidazolate frameworks-based nucleic acid delivery system in tumor diagnosis and therapy: a review. Biomedical Materials. 18(5). 52002–52002. 5 indexed citations

Zhang, Zhilei, Yonghua Wang, Xiangyan Zhang, et al.. (2023). Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression. iScience. 26(11). 108142–108142. 7 indexed citations

Ma, Guofeng, Guofang Zhang, Ye Liang, et al.. (2023). Presence, Subtypes, and Prognostic Significance of Tertiary Lymphoid Structures in Urothelial Carcinoma of the Bladder. The Oncologist. 29(2). e248–e258. 7 indexed citations

Gu, Lingwen, Guofeng Ma, Cui Li, Jing Lin, & Guiqiu Zhao. (2022). New insights into the prognosis of intraocular malignancy: Interventions for association mechanisms between cancer and diabetes. Frontiers in Oncology. 12. 958170–958170. 3 indexed citations

Ma, Guofeng, Zhilei Zhang, Zhao Zhang, et al.. (2022). Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment. Cell Communication and Signaling. 20(1). 114–114. 134 indexed citations

Zhang, Zhao, Yongbo Yu, Pengfei Zhang, et al.. (2021). Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer. BMC Cancer. 21(1). 18 indexed citations

Ma, Guofeng, Chun Li, Zhilei Zhang, et al.. (2021). Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies. Frontiers in Oncology. 11. 697894–697894. 30 indexed citations

10.

Yu, Yongbo, Ye Liang, Dan Li, et al.. (2021). Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment. Cell Death Discovery. 7(1). 15–15. 59 indexed citations

11.

Wang, Liping, Ting Xu, Xuecheng Yang, et al.. (2021). Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer. Frontiers in Molecular Biosciences. 8. 687305–687305. 20 indexed citations

12.

Xu, Xiaoyan, et al.. (2020). Establishment and Validation of a Prognostic Risk Model for Autophagy-Related Genes in Clear Cell Renal Cell Carcinoma. Disease Markers. 2020. 1–11. 6 indexed citations

13.

Ma, Guofeng, Ye Liang, Yuanbin Chen, et al.. (2019). Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer. Molecular Cancer Research. 18(2). 324–339. 62 indexed citations

14.

Ma, Guofeng, Xuecheng Yang, Ye Liang, et al.. (2018). Precision medicine and bladder cancer heterogeneity. Bulletin du Cancer. 105(10). 925–931. 19 indexed citations

15.

Wang, Liping, Xuecheng Yang, Dan Li, et al.. (2018). The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ. OncoTargets and Therapy. Volume 11. 7229–7243. 12 indexed citations

16.

Liang, Zhijuan, Yuanbin Chen, Liping Wang, et al.. (2018). CYP27A1 inhibits bladder cancer cells proliferation by regulating cholesterol homeostasis. Cell Cycle. 18(1). 34–45. 34 indexed citations

17.

Zhao, Desheng, et al.. (2009). Ectopic expression of macrophage scavenger receptor MARCO in synovial membrane‐like interface tissue in aseptic loosening of total hip replacement implants. Journal of Biomedical Materials Research Part A. 92A(2). 641–649. 6 indexed citations

18.

Ma, Guofeng, Nicole Verzijl, Roeland Hanemaaijer, et al.. (2006). Increased collagen degradation around loosened total hip replacement implants. Arthritis & Rheumatism. 54(9). 2928–2933. 27 indexed citations

19.

Ma, Guofeng, Mari Ainola, Mikko Liljeström, et al.. (2005). Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.. PubMed. 32(10). 1943–50. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact